SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche11/7/2008 11:11:01 AM
  Read Replies (2) of 411
 
Very frustrating, trying to grab hold of what is happening to this sucker today.

Yeron Werber, CitiGroup, downgraded the stock to sell. Some at Yahoo can't find an upgrade between now and his last downgrade to sell. Moreover, he had predicted, a year ago, that ranexa would NOT get this label expansion.

I do NOT follow the stock, but there is something extremely interesting going on here.... sales are ramping, and the company appears to be heading to profit WITHOUT the label expansion.

So..........????........... why the selling attack here? First line angina addresses a large, under-served market. What am I missing? TIA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News